Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

C. Faivre-Finn, D. R. Spigel, S. Senan, C. J. Langer, D. Raben, B. Perez, M. Ozguroglu, D. Daniel, A. Villegas, D. Vicente, R. Hui, S. Murakami, L. Paz-Ares, L. Poole, C. Wadsworth, P. A. Dennis, S. J. Antonia

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)488-488
JournalAnnals of Oncology
Volume29
Publication statusPublished - Oct 2018

Cite this

Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C. J., Raben, D., Perez, B., ... Antonia, S. J. (2018). Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. Annals of Oncology, 29, 488-488.